Best practice for analysis of shared clinical trial data.

Area of Science:

• Clinical trial data analysis
• Secondary research methodologies
• Health outcomes research

Background:

• Increasing demand for transparency in clinical trials.
• Maximizing patient-level data value for societal benefit.
• Categorization of shared clinical trial data analysis: reanalysis, meta-analysis, and supplemental analysis.

Discussion:

• Pre-specified analysis plans are crucial for interpreting shared clinical trial data.
• Acknowledging limitations in bias control and multiplicity compared to original trial design.
• Addressing challenges in planning, conducting, interpreting, and reporting secondary analyses.

Key Insights:

• Individual patient data in meta-analysis enhances precision and reduces bias.
• Supplemental analyses share limitations with broader epidemiological studies.
• Responsible data sharing necessitates transparency in research objectives, analysis plans, and results.

Outlook:

• Potential for significant benefit to future patients and society through data sharing.
• Importance of responsible data sharing practices to avoid misleading findings.
• Need for clear guidelines on transparency and interpretation of secondary analyses.